Synlett 2006(10): 1616-1618  
DOI: 10.1055/s-2006-944189
LETTER
© Georg Thieme Verlag Stuttgart · New York

Chelated Ester Enolates as Versatile Nucleophiles for Direct Nucleophilic Attack on Aromatic Nitro Groups

Daniel Stolz, Rigobert Pick, Uli Kazmaier*
Institut für Organische Chemie, Universität des Saarlandes, 66123 Saarbrücken, Germany
Fax: +49(681)3022409; e-Mail: u.kazmaier@mx.uni-saarland.de;
Further Information

Publication History

Received 13 March 2006
Publication Date:
12 June 2006 (online)

Abstract

Chelated amino acid ester enolates react with aromatic nitro compounds at the nitrogen atom. Best results were obtained with TFA-protected glycinates.

17

Probably, attack of the glycine nucleophile occurs according to Scheme [2] and one equiv of the enolate is necessary to reduce the nitro group. Attempts to trap the oxidized glycine species are currently under investigation.

18

Additions of Chelated Enolates towards Nitroarenes - General Procedure. The base used for enolate formation was prepared directly before use. In a Schlenk flask HMDS (428 mg, 2.65 mmol) was dissolved in THF (2 mL) under N2. Then, n-BuLi (1.6 M, 1.64 mL, 2.63 mmol) was added dropwise at -20 °C and the mixture was allowed to stir at r.t. for 10 min. After cooling at -78 °C a solution of ZnCl2 (187 mg, 1.38 mmol, dried previously in vacuo with a hot-air gun) was added with the amino acid derivative (1.25 mmol) in THF (3 mL). The suspension was stirred for further 30 min at -78 °C to form the chelated ester enolate. After that the nitroarene (0.5 mmol) was added in THF (1 mL). The solution was allowed to warm to r.t. overnight before it was diluted with Et2O (10 mL) and hydrolyzed in an ice bath with NH4OAc/HOAc buffer (pH 6, 10 mL). The layers were separated and the aqueous layer was extracted twice with Et2O. The combined organic layers were dried (Na2SO4) and the solvent was evaporated in vacuo. The crude product was purified by flash chromatography (silica, hexane-EtOAc).

19

Selected Spectroscopic and Analytical Data. tert -Butyl [(4-Chlorophenyl)(hydroxy)amino][(trifluoro-acetyl)amino]acetate ( 3a). Compound 3a was obtained from 2a (79 mg, 0.5 mmol) as a colorless solid; yield 175 mg (0.47 mmol, 95%); mp 101 °C. 1H NMR (500 MHz, CDCl3): δ = 1.40 (s, 9 H), 5.68 (d, J = 7.9 Hz, 1 H), 5.90 (s, 1 H), 7.14 (d, J = 8.8 Hz, 2 H), 7.23 (d, J = 8.8 Hz, 2 H), 7.56 (d, J = 7.6 Hz, 1 H). 13C NMR (125 MHz, CDCl3): δ = 27.8, 72.6, 84.8, 115.6 (q, J C,F = 286.1 Hz), 118.2, 128.7, 128.8, 147.4, 157.3 (q, J C,F = 37.2 Hz), 164.7. HMRS (CI): m/z [M]+ calcd for C14H16N2O4F3Cl: 368.0751. Found: 368.0746. Anal. Calcd for C14H16N2O4F3Cl (368.77): C, 45.59; H, 4.38; N, 7.59. Found: C, 45.28; H, 4.30; N, 7.57.
tert -Butyl [(4-Bromophenyl)(hydroxy)amino][(trifluoro-acetyl)amino]acetate ( 3b). Compound 3b was obtained from 2b (51 mg, 0.25 mmol) as a colorless solid; yield 91 mg (0.22 mmol, 88%); mp 98 °C. 1H NMR (500 MHz, CDCl3): δ = 1.39 (s, 9 H), 5.68 (d, J = 8.0 Hz, 1 H), 6.16 (br s, 1 H), 7.06 (d, J = 8.5 Hz, 2 H), 7.35 (d, J = 8.5 Hz, 2 H), 7.56 (d, J = 7.0 Hz, 1 H). 13C NMR (125 MHz, CDCl3): δ = 27.8, 72.5, 84.9, 114.3, 116.2, 118.5, 131.7, 147.9, 157.4 (q, J C,F = 38.5 Hz), 165.0.
HMRS (CI): m/z [M]+ calcd for C14H16N2O4F3Br: 412.02. Found: 412.0247. Anal. Calcd for C14H16N2O4F3Br (413.19): C, 40.69; H, 3.90; N, 6.78. Found: C, 40.82; H, 3.80; N, 6.76.
tert -Butyl [(4-Cyanophenyl)(hydroxy)amino][(trifluoro-acetyl)amino]acetate ( 3d). Compound 3d was obtained from 2d (104 mg, 0.70 mmol) as a colorless solid; yield 215 mg (0.60 mmol, 85%); mp 151 °C. 1H NMR (500 MHz, CDCl3): δ = 1.35 (s, 9 H), 5.80 (d, J = 7.5 Hz, 1 H), 6.32 (s, 1 H), 7.31 (d, J = 9.0 Hz, 2 H), 7.56 (d, J = 8.5 Hz, 2 H), 7.67 (d, J = 7.0 Hz, 1 H). 13C NMR (125 MHz, CDCl3): δ = 27.8, 71.8, 85.1, 105.4, 116.2, 116.6, 119.0, 133.1, 152.9, 157.4 (q, J C,F = 39.9 Hz), 164.1. HMRS (CI): m/z [M]+ calcd for C15H16N3O4F3: 359.1093. Found: 359.1082. Anal. Calcd for C15H16N3O4F3 (359.34): C, 50.14; H, 4.50; N, 11.69. Found: C, 50.18; H, 4.55; N, 11.53.
Methyl 4-[{2- tert -Butoxy-2-oxo-1-[(trifluoroacetyl)ami-no]ethyl}(hydroxy)amino]benzoate ( 3e). Compound 3e was obtained from 2e (18 mg, 0.10 mmol) as a colorless solid; yield 33 mg (84.1 µmol, 85%); mp 114 °C. 1H NMR (500 MHz, CDCl3): δ = 1.35 (s, 9 H), 3.86 (s, 3 H), 5.84 (d, J = 7.6 Hz, 1 H), 6.30 (br s, 1 H), 7.25 (d, J = 8.5 Hz, 2 H), 7.67 (d, J = 7.6 Hz, 1 H), 7.94 (d, J = 8.5 Hz, 2 H). 13C NMR (125 MHz, CDCl3): δ = 27.8, 51.9, 72.0, 84.8, 115.5 (q, J C,F = 286.1 Hz), 115.5, 124.4, 130.7, 153.0, 157.1, 164.5, 166.9. HMRS (CI): m/z [M]+ calcd for C16H19N2O6F3: 392.1195. Found: 392.1201. Anal. Calcd for C16H19N2O6F3 (392.37): C, 48.98; H, 4.89; N, 7.14. Found: C, 49.17; H, 4.87; N, 7.10.